• Untitled-design-88

Dr Paul Beavis is working towards better treatments

April 10th, 2017

A self-confessed sports fanatic, Dr Paul Beavis from the Peter MacCallum Institute in Melbourne, plays soccer, cricket, tennis, golf, squash and he also goes running regularly. He says getting out and active is a good way to let off steam after a frustrating day in the lab.

Dr Beavis’ job is at the cutting edge of breast cancer research, investigating how to turn the body’s immune system against cancer cells, so it’s not surprising that he has some trying days here and there.

About his research

breast cancer research
Dr Paul Beavis is an NBCF-funded breast cancer researcher

NBCF has funded Dr Beavis for four years to investigate ‘immunotherapy’, an innovative and potentially life-saving treatment for women with metastatic breast cancer – a stage of breast cancer doesn’t yet have effective treatments.

Immunotherapy has proven promising in other cancers, and now Dr Beavis is working on genetically engineering the immune system to recognise breast cancer cells. Ultimately this could lead to metastatic breast cancer being treatable – and also fewer side effects than standard radiotherapy and chemotherapy treatments.

NBCF recognises Dr Paul Beavis as an up-and-coming star of breast cancer research, and this is the second time he’s been funded for his work on immunotherapy.

His motivation

Like many Australians, Dr Beavis’ family has been touched by breast cancer. His grandmother is a breast cancer survivor, and many other people close to him have had cancer.

He’s driven to do research which will result in better care for those diagnosed with breast cancer and says the work is tremendously motivating and enjoyable.

Thanks to supporters

Dr Beavis is thankful to everyone who donates to breast cancer research and says, “We in the research community are very grateful for your efforts. We cannot do what we do without you.”

This NBCF funding that comes directly from the community will significantly increase the likelihood that his research will progress into a clinical trial and could be the next big breakthrough to save women’s lives.